TAK-070

Transfer of TAK-070, a Candidate Molecule for the Treatment of Alzheimer-type Dementia, to the National University Corporation
PharmaLive
Sat, 06/9/12 - 04:45 pm
Takeda
TAK-070
Alzheimer's disease